Le Lézard
Classified in: Health
Subjects: EXE, RCL, PSF

Food Recall Warning (Allergen) - Too Corny brand Salt & Vinegar Flavoured Gourmet Popcorn recalled due to undeclared milk


Product photos are available at http://bit.ly/2xDMcUV

OTTAWA, Sept. 29, 2017 /CNW/ - Too Corny Gourmet Popcorn is recalling Too Corny brand Salt & Vinegar Flavoured Gourmet Popcorn from the marketplace because it contains milk which is not declared on the label. People with an allergy to milk should not consume the recalled product described below.

The following product has been sold in Alberta.

Recalled product

 

Brand

Product

Size

UPC

Codes

Too Corny

Salt & Vinegar Flavoured Gourmet Popcorn

25 g

6 86773 00040 1

All codes where milk is not declared

Too Corny

Salt & Vinegar Flavoured Gourmet Popcorn

55 g

6 86773 00040 1

All codes where milk is not declared

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to milk, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by the Canadian Food Inspection Agency's (CFIA) inspection activities. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of this product.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 18:27
Andreozzi + Foote is deeply troubled by revelations of sexual abuse perpetrated by Ramon Garcia against patients at Carbon Health Urgent Care in Jenkintown and possibly other locations. Our client, Jane Doe, bravely stepped forward to share her...

at 18:14
SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/, a comprehensive, global resource facilitating...

at 18:08
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced with great respect and sorrow the unexpected passing last night of...

at 18:02
It takes a unique, special kind of dedication to become a nurse. For the nurses in First Nations and Inuit communities, it takes strength, resiliency, expertise, and most importantly, heart. It takes an understanding of the complex environment of...

at 17:44
On Tuesday, May 7, 2024, The Center for Discovery® (TCFD, The Center) honored Edward C. Sweeney, TCFD Board Chair, at the 24th annual Evening of Discovery Gala. The Gala was hosted by Mo Rocca, CBS Sunday Morning Correspondent, Humorist, and Creator...

at 17:30
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...



News published on and distributed by: